Encapsulating peritoneal sclerosis (EPS) is an uncommon but destructive complication of continuous peritoneal dialysis. EPS is a chronic inflammatory pathology classified as primary and secondary EPS. The classification depends on the pathologic findings of the encasing membrane and etiopathogenesis. Idiopathic EPS is known as abdominal cocoon syndrome. However, several etiologies, such as gynaecological infection, resulting in immunologic tissue damage, retrograde peritonitis, retrograde menstruation with viral infection, vascular anomalies, and omental hypoplasia, have been defined as secondary etiopathogenesis. Progressive peritoneal thickening, enclosure of the small bowel in fibrous tissue that results in small bowel obstruction, is a clinical presentation of EPS. Clinical findings are nonspecific. Radiological evaluation of EPS provides an early diagnosis and treatment and computed tomography (CT) scanning is a useful diagnostic method. The early diagnosis of EPS allows the detection of early-stage disease. In this paper, we present the demonstrative CT findings of EPS and evaluate radiological mimics of the disease.
Encapsulating Peritoneal Sclerosis
EPS, also defined as sclerosing encapsulating peritonitis or abdominal cocoon, is an uncommon but devastating complication of continuous peritoneal dialysis [1] . Progressive peritoneal thickening, enclosure of the small bowel in fibrous tissue that results in small bowel obstruction, is a clinical presentation of EPS [2] . This condition results from recurrent low-grade or subclinical peritonitis [3] .
EPS is a chronic inflammatory pathology classified as primary (idiopathic) and secondary EPS. The classification depends on the pathologic findings of the encasing membrane and etiopathogenesis [3] . Primary EPS is known as abdominal cocoon syndrome, and it is idiopathic [3] . However, several etiologies, such as gynaecological infection, resulting in immunologic tissue damage, retrograde peritonitis, retrograde menstruation with viral infection, vascular anomalies, and omental hypoplasia, have been defined [3] . Secondary EPS is more common than primary EPS, with several causative factors (Table 1) ; peritoneal dialysis is the most common [3] , in particular prolonged dialysis. Other factors include the use of chlorhexidine-and glucose-based dialysate and recurrent bacterial peritonitis [4] . The incidence of EPS in patients undergoing peritoneal dialysis is 2.5% [5] . As the duration of peritoneal dialysis increases, the incidence of EPS increases as well. In a study conducted among patients with peritoneal dialysis of 2, 5, 6, and 8 years, the rates of EPS were 1.9%, 6.4%, 10.8%, and 19.4%, respectively [4] .
EPS is associated with prominent morbidity and mortality due to small bowel obstruction, which causes intestinal insufficiency, malnutrition, sepsis, and death [4] . The mortality rate of EPS increases as the duration of dialysis increases. After 3 years of peritoneal dialysis, the mortality rate is 42%. After 15 years, it is 100% [5, 6] .
Clinical findings are nonspecific and include abdominal pain, malnutrition, appetite loss resulting in bowel changes, fever, and ascites [7] . Patients may be misdiagnosed with bacterial peritonitis, delaying diagnosis [8] . Over several years, membrane formation redirects intestinal obstruction. Membranes can develop in a period as short as 12 weeks [3] .
As the disease progresses, episodes of intermittent small bowel obstruction are observed due to the development of membranous tissue, kinking, and compression of bowel loops [3] . Rarely, bowel perforation occurs [9] . EPS is diagnosed by radiology or biopsy obtained during surgery. In patients with long-term peritoneal dialysis, with autoimmune conditions and intraperitoneal shunts, EPS should be considered in diagnosis [7] .
Radiological evaluation of patients with EPS provides an early diagnosis and treatment. CT scanning is a useful method in the diagnosis of EPS [8] . The main CT features of EPS can be divided into 4 major findings: (1) peritoneal findings (peritoneal thickening, calcification, and marked enhancement); (2) small bowel abnormalities (wall thickening, encapsulation, and dilation, leading to obstructive ileus with or without systemic inflammation); (3) fluid collection (loculated fluid collection and recurrent hemorrhagic ascites); and (4) calcification (liver and splenic capsule calcification, bowel calcification, and posterior peritoneal wall calcification) [10] .
The early diagnosis of EPS allows the detection of earlystage disease. This, in turn, may lead to shorter dialysis duration and earlier surgical treatment, which may include excision of the thickened peritoneum and non-viable bowel [6] . In addition, there are some medical treatment options, including the use of immunosuppressive agents such as prednisolone, sirolimus, or tamoxifen. The most conservative treatment option is to discontinue peritoneal dialysis and continue with total parenteral nutrition [1, 11] .
Peritoneal Findings
Three main pathologies are found in EPS: peritoneal thickening, calcification, and marked peritoneal enhancement [11] . All of these are caused by extensive peritoneal fibrosis due to widespread inflammation [8] .
The normal peritoneum is a thin structure, and its boundaries become visible in imaging procedures only after thickening. Peritoneal thickening in EPS may occur diffusely and be smooth, nodular, or calcified ( Figure 1 ) [8, 11] . Peritoneal thickening is observed in all EPS cases.
Peritoneal calcification begins as a small plaque-like nodule and spreads throughout the entire organ in advanced disease [11] . The levels of parathyroid hormone, vitamin D, and calcium phosphorus are high in patients with end-stage kidney diseases, increasing the possibility of dystrophic calcification [11] . Both the parietal peritoneum and visceral peritoneum are affected [6] . Peritoneal dialysis patients with severe, widespread peritoneal thickening and calcification are diagnosed as having EPS, and peritoneal dialysis may be interrupted ( Figure 2 ) [8] .
In imaging, peritoneal enhancement is a vague finding that is easily overlooked. It is best observed in areas of the peritoneum near low-attenuated structures such as fluid or fat (Figure 1 ). It is important to recognize such enhancement because it can indicate bacterial peritonitis, a common complication of peritoneal dialysis (Figure 3 ) [11] . Peritoneal thickening, calcification, and enhancement of its appearance in imaging studies may be seen in patients with pseudomyxoma peritonei, tuberculosis, peritoneal carcinomatosis, and mesothelioma. Appropriate clinical and imaging findings aid the correct diagnosis of these entities [6, 12] .
Small Bowel Abnormalities
The serosa of the small bowel is the location most commonly involved in EPS [13] . Similar to the peritoneum, small bowel lesions develop because of inflammatory fibrotic changes. Inflammatory reactions affect the small bowel wall, leading to thickening of the wall and mural fibrosis (Figure 4 ) [11] . The sclerosed peritoneum encapsulates the small bowel wall, and this causes dilation. Fibrotic and thickened peritoneum surrounds the small bowel loops, forms a retraction at the root of the mesentery, which causes bunching of the small bowel and leads to proximal-bowel obstruction and dysfunction. Tight enclosement of mesenteric roots of small bowel segments forms entrapment of bowel loops, which are tethered together. This finding is called a ''cocoon'' ( Figure 5 ) [14] . This is usually seen in the posterior area of loculated fluid collection [11] . Thus, these reactions may lead to necrosis and small bowel perforation [15] .
Fluid Collection
Patients receiving peritoneal dialysis have free fluid within the abdominal and pelvic cavity because of the dialysate fluid used in the procedure. Thus, the presence of free fluid is a common and nonspecific radiologic finding in EPS [8] . However, in EPS, fluid collection comprises loculated ascites secondary to fibrotic, thickened peritoneal membranes ( Figure 6 ) [4] . In addition, ''cocoon bowel'' can produce loculated fluid collection. The amount of fluid increases as EPS progresses [8] . The mass effect of increased fluid collection contributes to the formation of tethered and bunched together small bowel segments at the central location [8] . The structure and CT density of fluid collection depend on the content of the fluid. Fluid may be simple with homogeneous density or complex and hemorrhagic with heterogeneous density [2] . Depending on the peritoneal dialysis procedure, millimetric gas densities may be seen in these loculated fluid collections. Sepsis or perforation should be considered in the differential diagnosis of this condition [2] .
Calcification
Serosa or mural calcification over the liver and splenic capsule, bowel, and posterior peritoneal wall may develop in EPS. As mentioned above, calcifications may be nodular in form and are associated with advanced-stage disease. Capsular calcifications may be the result of abnormal calcium homeostasis (Figure 7 ) [11] .
Treatment and Prognosis of EPS
The first step in EPS treatment is to end peritoneal dialysis, give nutritional support, and change the dialysis method to hemodialysis. If intestinal obstruction occurs, surgery is required [11] .
EPS has a poor prognosis. As the disease progresses, the complications and risk for secondary pathologies increase. In advanced stages of disease, bowel obstruction is common. When surgery is performed for intestinal obstruction, patients have a high mortality within a few weeks or months. The mortality rate varies between 20%-80% [11] . Using biocompatible dialysates, immunosuppressive therapy and early diagnosis may decrease the mortality and morbidity rates of EPS [11] .
Discussion and Conclusion
EPS is a rare clinical condition. It can be divided as primary (idiopathic) and secondary forms. There are some findings that assist to differentiate primary EPS from secondary form. In primary EPS, it can present without adhesions between the loops. The only clinical sign in patients with primary EPS can be occurrences of several colic pains. However, as the patients with secondary EPS have risk factors, previous colic pain attack is associated with these risk factors. In primary EPS, bowel loops are tethered together in the abdominal centre with thickened peritoneum including calcifications. In secondary EPS, as the patients have clinical factors, only general intestinal occlusion may be diagnostic [12] .
EPS is a very important, progressive, and fatal complication of long-term peritoneal dialysis. After many dialysis episodes, patients presenting with weight loss, abdominal pain, nausea, and vomiting should be considered for the diagnosis. CT imaging may be the method of choice, providing a noninvasive, early diagnosis with some specific imaging findings.
